WaveMan
WaveMan · Company
NTHI · Neonc Technologies Holdings, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

NTHI Neonc Technologies (NTHI) Insider Trading, Ownership & Congress Trades

Pharma & Biotech · Pharmaceutical preparations · CIK 0001979414
Quote by TradingView
Cluster · 3 insidersC-suite buying · 3Form 144 · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
12
13F, latest reported quarter

What the filings say about NTHI

Insiders, 180 days
+$694.6K net bought
3 buyers · 1 seller · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$18.9K
1 notice

Neonc Technologies insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, NEONC TECHNOLOGIES HOLDINGS, INC. insiders bought a net $694.6K of stock across 66 Form 4 purchases and sales, with 3 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Heshmatpour Amir F
CEO, President
BUY
2026-09-15 SEC
35,000
$115.4K
-5.7%
Context
  • 27 earlier Form 4 trades (code P or S) here by this insider (23 buys, 4 sales), the last on Sep 14, 2026.
  • -20.1% median (-14.4% mean) 90-day return after 17 previous buys.
  • The trade is 1.1% of the 3,183,000 shares held after it.
  • 2 other insiders bought within 30 days.
  • 12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO, President Heshmatpour Amir F bought about $115.4K of NTHI on Sep 15, 2026; 2 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
GARNETT KEITHLY
CFO
SELL
2026-09-18 SECtraded 2026-09-15
5,000
$16.8K
-15.3%
Context
  • 9 earlier Form 4 trades (code P or S) here by this insider (5 buys, 4 sales), the last on Sep 14, 2026.
  • -29.2% median (-33.1% mean) 90-day return after 4 previous buys.
  • The trade is 2.1% of the 237,357 shares held after it.
  • No other insider sold within 30 days.
  • 12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO GARNETT KEITHLY sold about $16.8K of NTHI on Sep 15, 2026, the largest insider sale at the company since 2025; 12 funds added in the latest 13F quarter.
CHEN THOMAS C
CEO
BUY
2026-09-15 SECtraded 2026-09-14
5,242
$20.0K
-5.7%
Context
  • 13 earlier Form 4 trades (code P or S) here by this insider (9 buys, 4 sales), the last on Sep 11, 2026.
  • -24.1% median (-22.6% mean) 90-day return after 5 previous buys.
  • The trade is 21.4% of the 24,503 shares held after it.
  • 2 other insiders bought within 30 days.
  • 12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO CHEN THOMAS C bought about $20.0K of NTHI on Sep 14, 2026; 2 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
GARNETT KEITHLY
CFO
BUY
2026-09-15 SECtraded 2026-09-14
257
$1.0K
-5.7%
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (4 buys, 4 sales), the last on May 22, 2025.
  • -29.2% median (-33.1% mean) 90-day return after 4 previous buys.
  • The trade is 0.1% of the 242,357 shares held after it.
  • 2 other insiders bought within 30 days.
  • 12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO GARNETT KEITHLY bought about $1.0K of NTHI on Sep 14, 2026; 2 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
Heshmatpour Amir F
CEO, President
BUY
2026-09-15 SECtraded 2026-09-14
15,000
$59.4K
-5.7%
Context
  • 26 earlier Form 4 trades (code P or S) here by this insider (22 buys, 4 sales), the last on Sep 11, 2026.
  • -20.1% median (-14.4% mean) 90-day return after 17 previous buys.
  • The trade is 0.5% of the 3,148,000 shares held after it.
  • 2 other insiders bought within 30 days.
  • 12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO, President Heshmatpour Amir F bought about $59.4K of NTHI on Sep 14, 2026; 2 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
66 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 61 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net +$694.6K over 180 days
+$653.0K over 90 days · +$710.5K of it by a 10%+ holder
more than 86% of Pharma & Biotech
Congress
no House purchase disclosed in the last 12 months
Funds
12 funds bought in last quarter
below 79% of Pharma & Biotech
Revenue
-51.8% year over year
below 81% of Pharma & Biotech
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
10.8% of the float short (float per yahoo 2026-10-27) · 5.3 days to cover · settled 2026-10-15
below 57% of Pharma & Biotech
The situation: each line is one rule over one dataset
3 insiders bought a net $694.6K while the stock fell 39% over six months, but 1 Form 144 notice ($18.9K) are queued to sell.
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch NTHI

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-66.2%12M
-70%-33%+5%+42%2025-102025-122026-022026-042026-062026-082026-10 2026-09-11 · Heshmatpour Amir F bought $135.6K2026-08-14 · CHEN THOMAS C bought $130.0K2026-04-02 · Heshmatpour Amir F bought $121.8K2025-11-21 · Heshmatpour Amir F bought $119.6K2026-09-15 · Heshmatpour Amir F bought $115.4K2026-08-18 · CHEN THOMAS C bought $70.0K2026-09-14 · Heshmatpour Amir F bought $59.4K2026-04-08 · Heshmatpour Amir F bought $56.1K2026-08-18 · Heshmatpour Amir F bought $49.9K2026-04-10 · Heshmatpour Amir F bought $49.0K2026-04-23 · Heshmatpour Amir F bought $49.0K2026-04-24 · CHEN THOMAS C bought $48.0K2026-08-14 · Heshmatpour Amir F bought $45.5K2026-04-28 · Heshmatpour Amir F bought $45.2K2026-05-01 · Heshmatpour Amir F bought $41.6K2025-11-24 · Heshmatpour Amir F bought $39.1K2026-04-06 · Heshmatpour Amir F bought $31.6K2025-11-21 · Heshmatpour Amir F bought $26.0K2026-04-09 · Heshmatpour Amir F bought $26.0K2026-09-11 · CHEN THOMAS C bought $20.0K2026-09-14 · CHEN THOMAS C bought $20.0K2026-09-15 · GARNETT KEITHLY sold $16.8K2026-08-17 · Heshmatpour Amir F bought $13.1K2026-08-17 · CHEN THOMAS C bought $10.0K2025-11-20 · Neman-Ebrahim Yousha bought $7.4K2026-04-10 · CHEN THOMAS C bought $4.9K2026-04-23 · Neman-Ebrahim Yousha bought $2.4K2026-09-14 · GARNETT KEITHLY bought $1.0K2026-04-09 · SUH, DAVID JR. bought $1.0K2026-09-15 · KEITHLY GARNETT filed to sell $18.9K
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns NTHI: institutional holders (13F)

13F holdings, latest reported quarter
Cinctive Capital Management LP
1,607,464 sh
$7.3M
VANGUARD CAPITAL MANAGEMENT LLC
504,171 sh
$2.3M
BANK OF AMERICA CORP /DE/
224,412 sh
$1.0M
Westmount Partners, LLC
197,178 sh
$893.2K
BlackRock, Inc.
179,850 sh
$814.7K

Congress trades in NTHI

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

NTHI planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
KEITHLY GARNETT
Filed 2026-09-15
$18.9K

NTHI mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Ultra-Small Company Market Fund
$32.2K position · as of 2026-06-30
0.0%
iShares Micro-Cap ETF
$160.4K position · as of 2026-06-30
0.0%
1290 VT Micro Cap Portfolio
$10.7K position · as of 2026-06-30
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$852.5K position · as of 2026-06-30
0.0%
Fidelity Extended Market Index Fund
$250.5K position · as of 2026-05-31
0.0%
Fidelity Nasdaq Composite Index Fund
$56.2K position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
3 insiders reported buying shares.
The record shows a net $694.6K bought by insiders over 180 days, 12 funds added last quarter, $18.9K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
UTHRCPIXMRNAREGNLLYALNYMDGLCITRDNAVRTXNUVLTWST

NTHI financials

Revenue growth
-51.8%
XBRL, annual
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
n/a
average equity is zero or negative
Return on assets
-1,148%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
n/a
capital employed is zero or negative
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
n/a
no debt line filed
FCF yield
n/a
capex not filed for the four quarters
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-12
Revenue$40.0K$83.0K
Operating income-$58.2M-$7.1M
Net income-$62.1M-$11.9M
EPS (diluted)-3.20-0.69
Operating cash flow-$20.4M-$4.2M
Cash$58.7K$64.9K
SEC XBRL, fiscal years, as known on 2026-10-28

NTHI Stock Sonar score 4/7 axes

Find similar shapesCompare

NTHI ranks highest on insider conviction (87th percentile) and risk and compliance (36th), and lowest on growth (19th), among Pharma & Biotech peers.

Growth
19
Inputs
  • Revenue growth, YoY-51.8% · 19 pct, sector of 505
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
87
Inputs
  • Net Form 4 buying (codes P and S), 180d$695K · 85 pct, sector of 429
  • Insider buyers, 180d3 · 89 pct, sector of 438
Institutional and government
21
Inputs
  • Funds adding, latest quarter12 · 21 pct, sector of 698
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
36
Inputs
  • Short interest, % of float+10.8% · 36 pct, sector of 816
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Profitability, Financial health, US patents
  • Profitability needs 2 of 4 inputs, 1 present: average equity is zero or negative; capital employed is zero or negative; tax provision or pre-tax income not filed for the four quarters
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

NTHI filings, in plain words

Are Neonc Technologies insiders buying or selling NTHI?

In the 180 days to 2026-10-28, Neonc Technologies insiders were net buyers, a net $694.6K: $711.5K of purchases and $16.8K of sales reported on Form 4, by 3 buyers and 1 seller.

Are there planned insider sales of NTHI?

Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $18.9K of stock; the latest, by KEITHLY GARNETT, was filed 2026-09-15.

Read the full summary

In the 180 days to 2026-10-28, Neonc Technologies insiders were net buyers of NTHI, a net $694.6K across purchases and sales reported on Form 4 by 3 buyers and 1 seller. Most of that figure, $710.5K, came from a holder of 10% or more rather than an officer or director. Purchases outweighed sales more than tenfold by value. 3 different insiders reported purchases within the last 90 days, a cluster buy, which is rarer than a single purchase. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $18.9K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies